Tech Company Financing Transactions
Feldan Therapeutics Funding Round
On 3/30/2015, Feldan Therapeutics raised $1.2 million in Series C funding from Anges Quebec and Fier Succes.
Transaction Overview
Company Name
Announced On
3/30/2015
Transaction Type
Venture Equity
Amount
$1,200,000
Round
Series C
Investors
Anges Quebec (Xavier Harland)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4975 Rideau St. 100
Quebec QC, G2E 5H5
Canada
Quebec QC, G2E 5H5
Canada
Phone
Website
Email Address
Overview
We produce high-quality cytokines and proteins for your scientific needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Francois-Thomas Michaud
VP - Bus. Development
Vincent Ménard
VP - Bus. Development
Nancy Messier
VP - Marketing
Meriem Benchabane
VP - Operations
Pierre-Alain Moisset
VP - R & D
David Guay
Browse more venture capital transactions:
Prev: 3/30/2015: Dream Payments venture capital transaction
Next: 3/30/2015: Podo venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions on this site are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs